Lars W. Andersen, MD, MPH, PhD, DMSc1,2,3; Dan Isbye, MD, PhD4; Jesper Kjærgaard, MD, PhD, DMSc5; Camilla M. Kristensen, BS4; Søren Darling, MD6; Stine T. Zwisler, MD, PhD6; Stine Fisker, CRNA6; Jens Christian Schmidt, MD6; Hans Kirkegaard, MD, PhD, DMSc1,3; Anders M. Grejs, MD, PhD2; Jørgen R. G. Rossau, MD2; Jacob M. Larsen, MD, PhD7,8; Bodil S. Rasmussen, MD, PhD8,9; Signe Riddersholm, MD, PhD7,8,10; Kasper Iversen, MD, DMSc11,12; Martin Schultz, MD, PhD13; Jakob L. Nielsen, CRNA14; Bo Løfgren, MD, PhD1,10; Kasper G. Lauridsen, MD, PhD1,10,15; Christoffer Sølling, MD, PhD16; Kim Pælestik, MD16; Anders G. Kjærgaard, MD, PhD17; Dorte Due-Rasmussen, MD17; Fredrik Folke, MD, PhD12,18,19; Mette G. Charlot, MD, PhD18; Rikke Malene H. G. Jepsen, MD, PhD20; Sebastian Wiberg, MD, PhD20; Michael Donnino, MD21,22; Tobias Kurth, MD, PhD23; Maria Høybye, BS1; Birthe Sindberg, RN1; Mathias J. Holmberg, MD, MPH, PhD1,24; Asger Granfeldt, MD, PhD, DMSc2
doi : 10.1001/jama.2021.16628
JAMA. 2021;326(16):1586-1594
Previous trials have suggested that vasopressin and methylprednisolone administered during in-hospital cardiac arrest might improve outcomes.
Liam D. A. Paget, MD1,2,3; Gustaaf Reurink, PhD1,2,3,4; Robert-Jan de Vos, PhD5; Adam Weir, PhD5,6,7; Maarten H. Moen, PhD4,8; Sita M. A. Bierma-Zeinstra, PhD5,9; Sjoerd A. S. Stufkens, PhD1,2,3; Gino M. M. J. Kerkhoffs, PhD1,2,3; Johannes L. Tol, PhD2,3,10; for the PRIMA Study Group
doi : 10.1001/jama.2021.16602
JAMA. 2021;326(16):1595-1605
Approximately 3.4% of adults have ankle (tibiotalar) osteoarthritis and, among younger patients, ankle osteoarthritis is more common than knee and hip osteoarthritis. Few effective nonsurgical interventions exist, but platelet-rich plasma (PRP) injections are widely used, with some evidence of efficacy in knee osteoarthritis.
Emily Jane Woo, MD, MPH1; Adamma Mba-Jonas, MD, MPH1; Rositsa B. Dimova, PhD1; Meghna Alimchandani, MD1; Craig E. Zinderman, MD, MPH1; Narayan Nair, MD1
doi : 10.1001/jama.2021.16496
JAMA. 2021;326(16):1606-1613
As part of postauthorization safety surveillance, the US Food and Drug Administration (FDA) has identified a potential safety concern for Guillain-Barré syndrome (GBS) following receipt of the Ad26.COV2.S (Janssen/Johnson & Johnson) COVID-19 vaccine.
Timothy S. Anderson, MD, MAS1; John Z. Ayanian, MD, MPP2,3; Jeffrey Souza, MA4; Bruce E. Landon, MD, MBA4
doi : 10.1001/jama.2021.15286
JAMA. 2021;326(16):1627-1629
Elyse O. Kharbanda, MD, MPH1; Jacob Haapala, MPH1; Malini DeSilva, MD, MPH1; Gabriela Vazquez-Benitez, PhD1; Kimberly K. Vesco, MD, MPH2; Allison L. Naleway, PhD2; Heather S. Lipkind, MD, MS3
doi : 10.1001/jama.2021.15494
JAMA. 2021;326(16):1629-1631
Jeffrey T. Howard, PhD1; Corey S. Sparks, PhD2; Alexis R. Santos-Lozada, PhD3; Samson A. Olowolaju, MPH2; Jud C. Janak, PhD4; Krista J. Howard, PhD5
doi : 10.1001/jama.2021.13971
JAMA. 2021;326(16):1631-1633
Veronika W. Skrivankova, PhD1; Rebecca C. Richmond, PhD2,3; Benjamin A. R. Woolf, MSc2,4; James Yarmolinsky, PhD2,3; Neil M. Davies, PhD2,3,5; Sonja A. Swanson, ScD6; Tyler J. VanderWeele, PhD7; Julian P. T. Higgins, PhD3,8; Nicholas J. Timpson, PhD2,3; Niki Dimou, PhD9; Claudia Langenberg, PhD10,11; Robert M. Golub, MD12,13; Elizabeth W. Loder, MD14,15,16; Valentina Gallo, PhD17,18,19; Anne Tybjaerg-Hansen, MD, DMSc20; George Davey Smith, MD, DSc2,3,8; Matthias Egger, MD1,3,21; J. Brent Richards, MD22,23
doi : 10.1001/jama.2021.18236
JAMA. 2021;326(16):1614-1621
Mendelian randomization (MR) studies use genetic variation associated with modifiable exposures to assess their possible causal relationship with outcomes and aim to reduce potential bias from confounding and reverse causation.
R. Sean Morrison, MD1,2; Diane E. Meier, MD1; Robert M. Arnold, MD3
doi : 10.1001/jama.2021.16430
JAMA. 2021;326(16):1575-1576
Anne L. Dalle Ave, MD, MS1,2; Daniel P. Sulmasy, MD, PhD2,3
doi : 10.1001/jama.2021.16769
JAMA. 2021;326(16):1577-1578
Richard G. Frank, PhD1; Ezekiel J. Emanuel, MD, PhD2
doi : 10.1001/jama.2021.18308
JAMA. 2021;326(16):1579-1580
Michael O. Mensah, MD, MPH1
doi : 10.1001/jama.2021.17995
JAMA. 2021;326(16):1581-1582
Jason Haukoos, MD, MSc1,2; Ivor S. Douglas, MD3; Comilla Sasson, MD, PhD4
doi : 10.1001/jama.2021.15460
JAMA. 2021;326(16):1583-1585
William D. Leslie, MD, MSc1; Carolyn J. Crandall, MD, MS2,3
doi : 10.1001/jama.2021.9858
JAMA. 2021;326(16):1622-1623
Nabil M. Abou Baker, MD1; Andrew M. Davis, MD, MPH1
doi : 10.1001/jama.2021.11604
JAMA. 2021;326(16):1624-1625
Jennifer Abbasi
doi : 10.1001/jama.2021.13326
JAMA. 2021;326(16):1568-1570
Bridget M. Kuehn, MSJ
doi : 10.1001/jama.2021.18416
JAMA. 2021;326(16):1573
Bridget M. Kuehn, MSJ
doi : 10.1001/jama.2021.17973
JAMA. 2021;326(16):1573
Anita Slomski
doi : 10.1001/jama.2021.17441
JAMA. 2021;326(16):1572
Anita Slomski
doi : 10.1001/jama.2021.18589
JAMA. 2021;326(16):1572
Anita Slomski
doi : 10.1001/jama.2021.18590
JAMA. 2021;326(16):1572
Anita Slomski
doi : 10.1001/jama.2021.18591
JAMA. 2021;326(16):1572
Rita Rubin, MA
doi : 10.1001/jama.2021.17661
JAMA. 2021;326(16):1571
Rita Rubin, MA
doi : 10.1001/jama.2021.18645
JAMA. 2021;326(16):1571
Rita Rubin, MA
doi : 10.1001/jama.2021.18646
JAMA. 2021;326(16):1571
doi : 10.1001/jama.2021.15202
JAMA. 2021;326(16):1639
Kristin Walter, MD, MS1
doi : 10.1001/jama.2021.15882
JAMA. 2021;326(16):1642
Jeremy S. Faust, MD, MS1
doi : 10.1001/jama.2021.13870
JAMA. 2021;326(16):1633-1634
David T. Liss, PhD1; Cheryl L. Wilkes, MD1; Jeffrey A. Linder, MD, MPH1
doi : 10.1001/jama.2021.13882
JAMA. 2021;326(16):1634
Jodie M. Dodd, PhD1; Kathryn Dalrymple, PhD2; Jennie Louise, PhD1
doi : 10.1001/jama.2021.13992
JAMA. 2021;326(16):1634-1635
Amy G. Cantor, MD, MPH1; Rebecca M. Jungbauer, DrPH1; Roger Chou, MD1
doi : 10.1001/jama.2021.13995
JAMA. 2021;326(16):1635-1636
John C. Hagan III, MD1
doi : 10.1001/jama.2021.14060
JAMA. 2021;326(16):1636
Xavier Moisset, MD, PhD1; Geneviève Demarquay, MD, PhD2; Anne Ducros, MD, PhD3
doi : 10.1001/jama.2021.14063
JAMA. 2021;326(16):1636-1637
Zhen Wang, PhD1; Juliana H. VanderPluym, MD2; Mohammad Hassan Murad, MD, MPH1
doi : 10.1001/jama.2021.14069
JAMA. 2021;326(16):1637
آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟